Press Releases
To schedule a media interview with Arun Menawat, Chief Executive Officer, a urologist or a patient, please contact:
Stephen Kilmer
Investor Relations
647.872.4849 (Canada)
646.274.3580 (U.S)
Aaron Davidson
CFO and SVP of Corporate Development
647.476.1350
2018
Profound Medical Announces Preliminary Unaudited Fourth Quarter 2018 Revenues
January 3, 2019, Press Release
Profound Medical Announces Changes to Commercial Organization
December 14, 2018, Press Release
Profound Medical Announces Third Quarter 2018 Financial Results
November 8, 2018, Press Release
Profound Medical to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum
November 8, 2018, Press Release
Profound Medical to Present at the Stifel 2018 Health Conference
November 7, 2018, Press Release
Profound Medical to Release Third Quarter 2018 Financial Results on November 8 – Conference Call to Follow
October 30, 2018, Press Release
3-Year Clinical Outcomes and BPH Subgroup Analysis of Profound Medical’s Phase I Clinical Trial to be Included in Presentation at DGU 2018
September 18, 2018, Press Release
Profound Medical Files Preliminary Base Shelf Prospectus
September 6, 2018, Press Release
Profound Medical Announces Second Quarter 2018 Financial Results
August 14, 2018, Press Release
Profound Medical to Release Second Quarter 2018 Financial Results on August 14 – Conference Call to Follow
August 2, 2018, Press Release
Profound Medical Present at the Canaccord Genuity 38th Annual Growth Conference
July 31, 2018, Press Release
Profound Medical Announces Term Loan Agreement with CIBC Innovation Banking
July 31, 2018, Press Release
Profound Medical Corp. Announces Graduation to Toronto Stock Exchange
July 11, 2018, Press Release
Profound Medical Announces Annual Meeting of Shareholders Voting Results; Welcomes Two Industry Veterans as Independent Directors to its Board
June 14, 2018, Press Release
Initial Data from Profound Medical’s TACT Pivotal Clinical Trial Presented at AUA 2018
May 21, 2018, Press Release
Profound Medical Corp. Announces First Quarter 2018 Financial Results
May 10, 2018, Press Release
Profound Medical Corp. Announces Chinese Food and Drug Administration Approval for Sonalleve
May 9, 2018, Press Release
Profound Medical to Release First Quarter 2018 Financial Results on May 10, 2018 – Conference Call to Follow
May 2, 2018, Press Release
Profound Medical Further Strengthens Management Team with Appointment of Aaron Davidson as Chief Financial Officer and Senior Vice-President of Corporate Development
May 1, 2018, Press Release
Profound Medical to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference
April 25, 2018, Press Release
Accomplished International Medical Device Industry Executive, Ian Heynen, to Lead Profound Medical’s Sales & Marketing Function
April 23, 2018, Press Release
Profound Medical Corp. Announces Fourth Quarter and Full Year 2017 Financial Results
March 26, 2018, Press Release
Profound Medical Corp. Announces Closing of Bought Deal Financing
March 20, 2018, Press Release
Profound Medical to Release Fourth Quarter and Full Year 2017 Financial Results on March 26, 2018 – Conference Call to Follow
March 9, 2018, Press Release
Profound Medical Corp. Upsizes Previously Announced Bought Deal Financing
February 28, 2018, Press Release
Profound Medical Corp. Announces $20 Million Bought Deal Financing
February 27, 2018, Press Release
Profound Medical to Participate in 2018 BTIG Healthcare Conference
February 26, 2018, Press Release
Profound Medical Corp. Announces Completion of Patient Enrollment in TACT Pivotal Clinical Trial
January 31, 2018, Press Release
Profound Medical Corp. Announces Preliminary Fourth Quarter 2017 Revenue & Provides Progress Update on TACT Pivotal Trial Patient Enrollment
January 8, 2018, Press Release
2017
Profound Medical Corp. to Present at the 29th Annual Piper Jaffray Healthcare Conference
November 14, 2017, Press Release
Profound Medical Corp. Announces Third Quarter 2017 Financial Results
November 7, 2017, Press Release
Profound Medical Corp. Announces Expanded Clinical Use of TULSA-PRO® in Prostate Care to Include BPH
November 6, 2017, Press Release
October 26, 2017, Press Release
October 25, 2017, Press Release
Profound Medical Corp. Announces Closing of $10 Million “Bought Deal” Financing
September 20, 2017
Profound Medical Corp. Announces $10 Million “Bought Deal” Financing
August 24, 2017
Profound Medical Announces Second Quarter 2017 Financial Results
August 23, 2017
August 9, 2017
Profound Medical Corp. Completes Acquisition of Royal Philips’ Sonalleve MR-HIFU Business
July 31, 2017
June 30, 2017
Profound Medical Corp. Announces Annual Meeting of Shareholders Voting Results
May 24, 2017
Profound Medical Corp. Announces First Quarter 2017 Financial Results
May 9, 2017
Profound Medical to Present at the CIBC Technology & Innovation Conference 5.0
May 3, 2017
April 25, 2017
Profound Medical Corp. Obtains DTC Eligibility for its Common Shares in the U.S.
April 18, 2017
Profound Medical Corp. Announces First Paid Procedure Using TULSA-PRO® System
March 27, 2017
Profound Medical Corp. Announces Management Change
March 24, 2017
March 20, 2017
Profound Medical Corp. to Begin Trading on OTCQX on March 13, 2017
March 9, 2017
Profound Medical Corp. Announces Fourth Quarter and Full Year 2016 Financial Results
March 6, 2017
February 21, 2017
February 14, 2017
Profound Medical Announces Special Meeting of Shareholders Voting Results
January 26, 2017
Profound Medical Announces Appointment of Kenneth Galbraith to its Board of Directors
January 17, 2017
2016
Profound Medical Corp. Announces Third Quarter 2016 Financial Results
November 16, 2016
November 14, 2016
November 3, 2016
Profound Medical Corp. to Present at the Stifel 2016 Healthcare Conference
November 1, 2016
October 26, 2016
Profound Medical Corp. Announces $17.4 Million Bought Deal Financing
October 17, 2016
Profound Medical Receives Frost & Sullivan’s 2016 New Product Innovation Award
October 5, 2016
September 22, 2016
Profound Medical Corp. Announces Second Quarter 2016 Financial Results
August 18, 2016
Profound Medical Corp. Announces Senior Management Changes to Support Global Growth Strategy
August 15, 2016
Profound Medical Corp. to Release Second Quarter 2016 Financial Results on August 18, 2016
August 10, 2016
Profound Medical Corp. Announces Annual Meeting of Shareholders Voting Results
June 22, 2016
Profound Medical Corp. and Philips Sell TULSA-PROTM System to Cologne, Germany
June 21, 2016
Profound Medical Corp, and Philips Sell TULSA-PROTM System to UCL and UCLH
June 20, 2016
Profound Medical Corp. to hold Annual General Meeting of the Shareholders
June 7, 2016
FDA Grants Profound Medical Corp. IDE Approval for TULSA-PROTM
May 19, 2016
May 11, 2016
Profound Medical Corp. Announces First Quarter 2016 Financial Results
May 6, 2016
Profound Medical Corp. to Present at Upcoming Conference
April 29, 2016
Profound Medical Corp. to Release First Quarter 2016 Financial Results on May 6, 2016
April 29, 2016
Profound Medical Corp. Announces World’s First Sale of TULSA-PRO for Prostate Ablation
April 28, 2016
Profound Medical Corp., receives CE Mark Approval for TULSA-PRO
April 11, 2016
March 12, 2016
February 29, 2016
Profound Medical Corp. to Release Full Year 2015 Financial Results on March 3, 2016
February 25, 2016
Profound Medical Corp., Announces Publication in European Urology
January 8, 2016, Press Release
2015
Profound Medical named 2016 Life Science Company of the Year
November 27, 2015, Press Release
A Brighter Future: Advancements in Prostate Therapy Minimize Side Effects for Patients
November 20, 2015, Media Planet Supplement, Toronto Star
Profound Medical Corp. Announces Departure of CFO
November 17, 2015, Press Release
Things to Consider When Going Public
OnBoard Magazine Fall 2015
Profound Medical Corp. Announces Third Quarter 2015 Financial Results
November 4, 2015, Press Release
Hartmut Warnken joins Profound Medical as Vice President, International Sales
November 2, 2015, Press Release
Profound Medical Corp. to Release Third Quarter 2015 Financial Results on November 4, 2015
October 28, 2015, Press Release
Profound Medical to Present at Upcoming Investor Conferences
October 21, 2015, Press Release
October 15, 2015, Press Release
October 13, 2015, Press Release
Profound Medical Announces Grant of Share Options
September 18, 2015, Press Release
Profound Medical Corp. Announces Second Quarter 2015 Financial Results
August 25, 2015, Press Release
Profound Medical Corp. Announces First Quarter 2015 Financial Results of Profound Medical Inc.
July 29, 2015, Press Release
Philips and Profound Medical Collaborate to Advance Treatment for Prostate Cancer Patients
July 21, 2015, Press Release
Profound Medical Corp. Announces Annual Meeting of Shareholders Voting Results
June 23, 2015, Press Release
Profound Medical Opens the Market
June 15, 2015, Press Release
Profound Medical Goes Public via Reverse Takeover
June 1, Biotechnology Focus
Profound Medical Corp. Announces Closing of Qualifying Transaction
June 4, 2015, Press Release
Preclinical safety and feasibility with 28-day follow-up
May 2015, Journal of Urology, Vol. 192
Profound Medical seeking CE Mark for TULSA-PRO This Year
May 26, 2015, Bio Tuesdays
Profound Medical and Shopify show Contrasting Ways to go Public
May 25, 2015, Financial Post
Mira IV Acquisition Corp. Announces Filing of Filing Statement
May 25, 2015, Press Release
April 30, 2015, Press Release
Mira IV Acquisition Corp. Announces entering into of an Amalgamation Agreement with PMI
April 29, 2105, Press Release
CEO Steve Plymale participates in panel: Meet the Entrepreneurs – Health
April 15, 2015, MaRS video
OnBoard Magazine, Page 23, Spring 2015
Best Poster for Session, New Technologies in the OR, EAU 2015
March 2015, EAU Madrid
2014
New minimally invasive prostate cancer treatment offers hope to patients
Media Planet, Cancer Care, November 13, 2014
Mira IV Acquisition Corp. announces proposed Qualifying Transaction with Profound Medical Inc.
November 5, 2014, Press Release
Profound Medical appoints Shameze Rampertab as CFO
October 15, 2014, Press Release
Profound Medical appoints Dr. Arun Menawat to Board of Directors
October 17, Press Release
Enrollment closes for TULSA safety and feasibility clinical trial
April 11, 2014, Press Release
Beaumont Hospital first in U.S. to treat patient with TULSA
February 17, 2014, Press Release
2013
April 25, 2013, Press Release
World First in Prostate Cancer Treatment at LHSC
April 24, 2013, CTV News
Clinical Trial First for Less Invasive procedure to treat prostate cancer
April 24, 2013, Globe and Mail
September 17, 2013, Press Release
Upcoming Events
Meet Profound Medical at these Upcoming Meetings and Conferences
Annual Society of Thermal Medicine Meeting, Tucson
May 7-10, 2018
German Radiology Congress (RöKo), Leipzig
May 9-12, 2018
International Symposium for Therapeutic Ultrasound (ISTU), Nashville
May 14-17, 2018
American Urological Association Annual Meeting (AUA), San Francisco
May 18-21, 2018
106734A